Skip to main content
Log in

Zellspezifische Aptamere in Diagnostik und Therapie

  • Wissenschaft / Methoden
  • Zell-SELEX
  • Published:
BIOspektrum Aims and scope

Zusammenfassung

Mittels Zell-SELEX lassen sich Aptamere selektieren, die intakte Zellen spezifisch erkennen. Anwendungen liegen in der Identifizierung von Zellpopulationen sowie in der Therapie, da zellspezifische Aptamere regulatorische Effekte auf Zielzellen ausüben oder Wirkstoffe vermitteln können.

Abstract

Cell-SELEX allows the selection of aptamers that specifically recognize live target cells. Applications include isolation and identification of cell populations or their constituents. Furthermore, some of these aptamers show regulatory effects or deliver specific drugs and may therefore be promising therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510

    Article  PubMed  CAS  Google Scholar 

  2. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822

    Article  PubMed  CAS  Google Scholar 

  3. Mayer G (2009) The Chemical Biology of Aptamers. Angew Chem Int Ed 48:2672–2689

    Article  CAS  Google Scholar 

  4. Homann M, Goringer HU (1999) Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res 27:2006–2014

    Article  PubMed  CAS  Google Scholar 

  5. Blank M, Weinschenk T, Priemer M et al. (2001) Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels — Selective targeting of endothelial regulatory protein pigpen. J Biol Chem 276:16464–16468

    Article  PubMed  CAS  Google Scholar 

  6. Daniels DA, Chen H, Hicke BJ et al. (2003) A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci USA 100:15416–15421

    Article  PubMed  CAS  Google Scholar 

  7. Shangguan D, Li Y, Tang ZW et al. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103:11838–11843

    Article  PubMed  CAS  Google Scholar 

  8. Raddatz MSL, Dolf A, Endl E et al. (2008) Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew Chem Int Ed 47:5190–5193

    Article  CAS  Google Scholar 

  9. Avci-Adali M, Metzger M, Perle N et al. (2010) Pitfalls of Cell-Systematic Evolution of Ligands by Exponential Enrichment (SELEX): Existing Dead Cells During In Vitro Selection Anticipate the Enrichment of Specific Aptamers. Oligonucleotides 20:317–323

    Article  PubMed  CAS  Google Scholar 

  10. Dollins CM, Nair S, Boczkowski D et al. (2008) Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer. Chem Biol 15:675–682

    Article  PubMed  CAS  Google Scholar 

  11. Mann AP, Somasunderam A, Nieves-Alicea R et al. (2010) Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting. Plos One 5:e13050

    Article  PubMed  Google Scholar 

  12. McNamara JO, Andrechek ER, Wang Y et al. (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.. Nat Biotechnol 24:1005–1015

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Rentmeister.

Additional information

Cindy Meyer Jahrgang 1982. 2001–2006 Biochemiestudium, Universität Leipzig; Diplomarbeit am Institut für Biochemie unter Anleitung von Prof. Dr. Beck-Sickinger. 2006–2009 Promotion am Institut für Biochemie und Molekularbiologie bei Prof. Dr. Hahn, Universität Hamburg. Seit 2010 Postdoctoral Fellow, Institut für Biochemie und Molekularbiologie, Universität Hamburg.

Ulrich Hahn Jahrgang 1950. Studium der Agrarwissenschaften und Biologie (Hauptfach Mikrobiologie), Universität Göttingen. 1980 Promotion am Max-Planck-Institut für experimentelle Medizin, Göttingen. 1982 Akademischer Rat, FU Berlin. 1993 Hochschuldozent, Medizinische Universität zu Lübeck. 1994 Professur für Allgemeine und Mikrobielle Biochemie, Universität Leipzig und 2002 Professur für Biochemie und Molekularbiologie, Universität Hamburg.

Andrea Rentmeister Jahrgang 1977. Chemiestudium in Graz, Österreich und Bonn. 2007 Promotion bei Prof. Dr. Famulok im Bereich Aptamere und Riboswitches, Universität Bonn. 2007–2010 Postdoc bei Prof. Dr. Arnold im Bereich Protein-Engineering am California Institute of Technology, Pasadena, CA, USA. Seit 2010 Junior-Professorin an der Universität Hamburg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer, C., Hahn, U. & Rentmeister, A. Zellspezifische Aptamere in Diagnostik und Therapie. Biospektrum 17, 411–413 (2011). https://doi.org/10.1007/s12268-011-0065-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12268-011-0065-8

Navigation